Danaher offers concessions in EU review of GE BioPharma deal
Danaher has offered to amend its acquisition of GE Healthcare Life Science's BioPharma business in a bid to win EU clearance. The concession offer has triggered a 10 working-day extension to the...To view the full article, register now.
Already a subscriber? Click here to view full article